One of the side effects of the COVID-19 pandemic has been a systematic re-evaluation of how cancer care is delivered in the United States. The usage of telehealth appointments in oncology has risen rapidly since March 2020, and recent society guidelines now suggest several strategies for decreasing the frequency of cancer therapy infusions. [1][2][3] Journeying through a global pandemic with a diagnosis of cancer has undoubtedly been stressful for patients and their caregivers, both because of fear of the novel coronavirus itself and also because of uncertainties regarding delays in cancer care. However, one silver lining of the COVID-19 pandemic-borne out of the desire to keep our patients and clinicians safe-has been a renewed emphasis on maximizing how much time patients can spend at home.Author affiliations and support information (if applicable) appear at the end of this article.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.